Increasing diversity through the NCI SBIR development centre
Increasing diversity through the NCI SBIR development centre
The importance of online patient groups and 'The ROS1ders'
Effects of dasatinib on xenograft lung tumour models with YES1 overexpression
Analysis tools for NCI genomic databases
Results from GOBACK: Non-chromosomal birth defects linked with cancer
A link between non-chromosomal birth defects and cancer
Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes
Clinical development and economic prospects of CAR T cell immunotherapies
Theranostic imaging of lymphoma using radiolabelled αCD19-antibodies
Doubled survival in metastatic lung cancer with combination therapy
Results from CheckMate-227 : Immune combination reaches PFS endpoint
Editor’s Choice for March 2018